The Prostate

Cover image for Vol. 71 Issue 16

December 2011

Volume 71, Issue 16

Pages 1711–1824

  1. Original Articles

    1. Top of page
    2. Original Articles
    1. Active sonic hedgehog signaling between androgen independent human prostate cancer cells and normal/benign but not cancer-associated prostate stromal cells (pages 1711–1722)

      Katsumi Shigemura, Wen-Chin Huang, Xiangyan Li, Haiyen E. Zhau, Guodong Zhu, Akinobu Gotoh, Masato Fujisawa, Jingwu Xie, Fray F. Marshall and Leland W. K. Chung

      Version of Record online: 25 APR 2011 | DOI: 10.1002/pros.21388

    2. Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression (pages 1723–1735)

      David P. Turner, Victoria J. Findlay, Omar Moussa, Victor I. Semenchenko, Patricia M. Watson, Amanda C. LaRue, Mohamed M. Desouki, Mostafa Fraig and Dennis K. Watson

      Version of Record online: 28 MAR 2011 | DOI: 10.1002/pros.21389

    3. A Three-Gene panel on urine increases PSA specificity in the detection of prostate cancer (pages 1736–1745)

      Marina Rigau, Israel Ortega, Maria Carmen Mir, Carlos Ballesteros, Marta Garcia, Marta Llauradó, Eva Colás, Núria Pedrola, Melania Montes, Tamara Sequeiros, Tugce Ertekin, Blanca Majem, Jacques Planas, Anna Ruiz, Miguel Abal, Alex Sánchez, Juan Morote, Jaume Reventós and Andreas Doll

      Version of Record online: 25 APR 2011 | DOI: 10.1002/pros.21390

    4. Is atypical adenomatous hyperplasia of the prostate a precursor lesion? (pages 1746–1751)

      Chen Zhang, Rodolfo Montironi, Gregory T. MacLennan, Antonio Lopez-Beltran, Yan Li, Puay-Hoon Tan, Mingsheng Wang, Shaobo Zhang, Kenneth A. Iczkowski and Liang Cheng

      Version of Record online: 7 APR 2011 | DOI: 10.1002/pros.21391

    5. Neuroendocrine tumor cells in prostate cancer: Evaluation of the neurosecretory products serotonin, bombesin, and gastrin – impact on angiogenesis and clinical follow-up (pages 1752–1758)

      Elmar Heinrich, Lutz Trojan, Dorothee Friedrich, Martin Voß, Christel Weiss, Maurice Stephan Michel and Rainer Grobholz

      Version of Record online: 7 APR 2011 | DOI: 10.1002/pros.21392

    6. Passive bioelectrical properties for assessing high- and low-grade prostate adenocarcinoma (pages 1759–1767)

      Ryan J. Halter, Alan R. Schned, John A. Heaney and Alex Hartov

      Version of Record online: 25 APR 2011 | DOI: 10.1002/pros.21393

    7. BRCA1 mutations do not increase prostate cancer risk: Results from a meta-analysis including new data (pages 1768–1779)

      Laura Fachal, Antonio Gómez-Caamaño, Catuxa Celeiro-Muñoz, Paula Peleteiro, Ana Blanco, Ana Carballo, Jerónimo Forteza, Ángel Carracedo and Ana Vega

      Version of Record online: 25 APR 2011 | DOI: 10.1002/pros.21394

    8. Quantification of extraprostatic perineural spread and its prognostic value in pT3a pN0 M0 R0 prostate cancer patients (pages 1790–1795)

      Klaus Aumayr, Michael Breitegger, Peter R. Mazal, Anke Koller, Michael Marberger, Martin Susani and Andrea Haitel

      Version of Record online: 11 MAY 2011 | DOI: 10.1002/pros.21396

    9. Combined treatment targeting HIF-1α and Stat3 is a potent strategy for prostate cancer therapy (pages 1796–1809)

      Kavitha Ramasamy Reddy, Yongli Guan, Guoting Qin, Zhou Zhou and Naijie Jing

      Version of Record online: 7 APR 2011 | DOI: 10.1002/pros.21397

    10. Chemotherapy sensitivity recovery of prostate cancer cells by functional inhibition and knock down of multidrug resistance proteins (pages 1810–1817)

      Catherine Sánchez, Alejandro Mercado, Héctor R. Contreras, Patricia Mendoza, Juan Cabezas, Cristian Acevedo, Christian Huidobro and Enrique A. Castellón

      Version of Record online: 7 APR 2011 | DOI: 10.1002/pros.21398

    11. Statins increase the risk of prostate cancer: A population-based case–control study (pages 1818–1824)

      Chih-Ching Chang, Shu-Chen Ho, Hui-Fen Chiu and Chun-Yuh Yang

      Version of Record online: 7 APR 2011 | DOI: 10.1002/pros.21401